Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03LGX
|
||||
| Former ID |
DIB001694
|
||||
| Drug Name |
NI-105
|
||||
| Synonyms |
NI-105; Tau protein modulator (neurodegenerative disease); Tau protein modulator (neurodegenerative disease), Biogen Idec; Tau protein modulator (neurodegenerative disease), Neurimmune Therapeutics
|
||||
| Indication | Neurodegenerative disease [ICD9: 330-337; ICD10:G30-G32] | Investigative | [531616] | ||
| Company |
Neurimmune Therapeutics AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | Microtubule-associated protein tau | Target Info | Modulator | [531616] | |
| KEGG Pathway | MAPK signaling pathway | ||||
| Alzheimer's disease | |||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| Pathway Interaction Database | LPA receptor mediated events | ||||
| Reelin signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.